Publication

Article

Cardiology Review® Online

April 2007
Volume24
Issue 4

Treatment options for atrial fibrillation in a 62-year-old man

A 62-year-old man with paroxysmal atrial fibrillation (AF) presents to his physician’s office for a discussion of treatment options for his AF.

A 62-year-old man with paroxysmal atrial fibrillation (AF) presents to his physician’s office for a discussion of treatment options for his AF. He has no history of hypertension or other stroke risk factors, and echocardiography indicates normal left ventricular function and left atrial size. He is highly symptomatic during his AF episodes despite treatment with β blockers for rate control. He is prescribed amiodarone to maintain sinus rhythm. Should this patient also be prescribed an angiotensin-converting enzyme inhibitor or an angiotensin-receptor blocker to enhance the efficacy of rhythm control?

Related Videos
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Viet Le, DMSc, PA-C | Credit: APAC
Marianna Fontana, MD, PhD: Declines in Kidney Function Frequent in ATTR-CM  | Image Credit: Radcliffe Cardiology
© 2024 MJH Life Sciences

All rights reserved.